Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place

Jingyuan Zhang1,2,3,4,5, Jun Yang1,2,3,4,5, Cheng Yang1,2,3,4,5

  • 1Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Psychiatry
|October 2, 2020
PubMed

Insights

Gut microbiota composition changes with morphine exposure and is linked to reward sensitivity. These findings offer potential new strategies for treating opioid use disorder.

Area of Science:

  • Microbiology
  • Neuroscience
  • Pharmacology

Background:

  • The gut microbiota and central nervous system share a bidirectional relationship.
  • Gut microbiota alterations are linked to mental health disorders, including opioid use disorders.
  • Morphine exposure disrupts gut microbiota, but its connection to morphine reward sensitivity is unclear.

Purpose of the Study:

  • To investigate the association between gut microbiota composition and morphine reward sensitivity.
  • To determine if morphine exposure alters gut microbiota and if these changes correlate with reward sensitivity.

Main Methods:

  • Used the conditioned place preference (CPP) paradigm in morphine-treated and saline-treated rats.
  • Analyzed fecal bacterial communities using 16S rRNA sequencing at baseline and post-conditioning.
  • Compared microbial composition between morphine-treated and saline-treated groups, and between low and high CPP groups.

Main Results:

  • Morphine treatment altered gut microbial composition but not alpha diversity compared to saline controls.
  • Significant differences in microbial composition existed between low and high CPP groups both before and after morphine treatment.
  • Specific taxa, including *Alloprevotella* and *Romboutsia*, showed correlations with CPP scores.

Conclusions:

  • Morphine exposure alters gut microbiota composition in rats.
  • Gut microbial alterations are correlated with an individual's sensitivity to morphine reward.
  • Findings suggest potential for novel therapeutic and preventive strategies for opioid use disorder targeting the gut microbiota.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.4K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
646
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
743